A new ulcer model, 'unhealed gastric ulcers', induced by chronic treatment with indomethacin in rats with acetic acid ulcers

Journal of Physiology and Pharmacology

Volumn 50, Issue 2, 1999, Pages 169-181

  Amagase, K ^b   Okabe, Susumu ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

'unhealed gastric ulcer'; Acetic acid ulcer; Acid pump inhibitor; Indomethacin; Sucralfate

Indexed keywords

ALUMINUM HYDROXIDE; CIMETIDINE; INDOMETACIN; OMEPRAZOLE; SUCRALFATE;

ARTICLE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; MALE; NONHUMAN; RAT; STOMACH ULCER; ULCER HEALING;

ACETIC ACID; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; GASTRIC ACID; INDOMETHACIN; MALE; RATS; STOMACH ULCER; WOUND HEALING;

EID: 0033030087     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Takagi K, Okabe S, Saziki R. A new method for the production of chronic gastric ulcer in rats and the effect of several drugs on its healing. Jpn J Pharmacol 1969; 19: 418-426.
2. Okabe S, Roth JLA, Pfeiffer CJ. A method for experimental, penetrating gastric and duodenal ulcers in rats. Am J Dig Dis 1971; 16: 277-284.
3. Konturek SJ, Dembinski A, Warzecha Z, Brzozowski T, Gregory H. Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats. Gastroenterology 1988; 94: 1300-1307.
4. Satoh H, Inatomi N, Nagaya et al. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats. J Pharmacol Exp Ther 1989; 248: 806-815.
5. Okabe S, Takagi K, Inoue K. Effect of NC-1300-O-3 on healing of acetic acid-induced gastric ulcers in rats. Jpn J Pharmacol 1993; 62: 25-33.
6. Satoh H, Sato F, Asano S, et al. Role of endogenous basic fibroblast growth factor in the healing of gastric ulcers in rats. Jpn J Pharmacol 1997; 73: 59-71.
7. Szelenyi I, Engler H, Herzog P, Postius S, Vergin H, Holtermuller KH. Influence of non-steroidal anti-inflammatory compounds on healing of chronic gastric ulcers in rats. Agents Actions 1980; 12: 180-182.
8. Wang JY, Yamasaki S, Takeuchi K, Okabe S. Delayed healing of acetic acid-induced gastric ulcers in rats by indomethacin. Gastroenterology 1989; 96: 393-402.
9. Hirose H, Takeuchi K, Okabe S. Effect of indomethacin on gastric mucosal blood flow around acetic acid-induced gastric ulcers in rats. Gastroenterology 1991; 100: 1259-1265.
10. Okabe S, Miyake H, Yamasaki S. Effects of NC-1300, a gastric proton pump inhibitor, on healing of acetic acid-induced gastric ulcers in rats. Dig Dis Sci 1989; 34: 1035-1042.
11. Ogihara Y, Fuse Y, Okabe S. Effect of indomethacin and prednisolone on connective tissue at the base of acetic acid-induced gastric ulcers in rats. In: Mechanisms of Injury, Protection and Repair of the Upper Gastrointestinal Tract. A Garner, PE O'Brien (eds). Chichester, Wiley Publishers, 1991, pp. 455-465.
12. Lam SK. Therapy of gastric ulcer disease. In: Sucralfate. From the basic science to the bedside. D. Hollander D, GNJ Tytgat (eds). New York, Plenum Medical, 1993, pp. 239-247.
13. Okabe S, Takeuchi K, Kunimi H, Kanno M, Kawashima M. Effects of an antiulcer drug, sucralfate (a basic aluminum salt of sulfated disaccharide), on experimental gastric lesion and gastric secretion in rats. Dig Dis Sci 1983; 28: 1034-1042.
14. Morris GP. Binding of sucralfate to the mucosal surface. In: Sucralfate. From the basic science to the bedside. D. Hollander, GNJ Tytgat (eds). New York, Plenum Medical, 1993, pp. 71-82.
15. Ogihara Y, Okabe S. Effect and mechanism of sucralfate on healing of acetic acid-induced gastric ulcers in rats. J Physiol Pharmacol 1993; 44: 109-118.
16. Konturek SJ, Konturek JE, Brzozowski T, Slomiany BL, Slomiany A. Effect of sucralfate on growth factor availability. In: Sucralfate. From the basic science to the bedside. D. Hollander, GNJ Tytgat (eds). New York, Plenum Medical 1993, pp. 175-189.
17. Szabo S, Folkman J, Vincze A, Sandor Zs, Gombos Z. Modulation of vascular facors by VEGF/VPF (vascular endothelial cell growth factor/vascular permeability factor) is sufficient for chronic ulcer healing and acute gastroprotection. Gastroenterology 1997; 112: A303.
18. Szabo S, Vincze A, Sandor Zs, Gombos Z. Vascular approach to gastroduodenal ulceration: new studies with endothelins and VEGF. Dig Dis Sci 1998; 43: 40S-45S.
19. Tarnawski A, Sekhon S, Ichikawa Y, Sarfewh IJ. Vascular endothelial growth factor (VEGF) enhances angiogenesis in injured gastric mucosa and accelerates healing of ethanol-induced erosions. Gastroenterology 1998; 114: A307.
20. Folkman J, Szabo S, Shing Y. Sucralfate affinity for fibroblast growth factor. J Cell Biol 1991; 111:223A.
21. Folkman J, Szabo S, Stovroff M. Duodenal ulcer: discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann Surg 1991; 214: 414-426.
22. Ito M, Imai S, Joh T et al. Effect of epidermal growth factor in combination with sucralfate or omeprazole on the healing of chronic gastric ulcers in the rat. J Clin Gastroenterol 1990; 12 (suppl 1): S187-S191.
23. Tarnawski A, Stachura J, Douglass TG, Krause WJ, Gergely H, Sarfeh IJ. Indomethacin impairs quality of experimental gastric ulcer healing: a quantitative histological and ultrastructural analysis. In: Mechanisms of Injury, Protection and Repair of the Upper Gastrointestinal Tract. A Garner, PE O'Brien (eds). Chichester, Wiley Publishers, 1991, pp. 521-531.
24. Rachmilewitz D. Stimulation of mucosal prostaglandins by sucralfate. In Sucralfate. From the basic science to the bedside. D. Hollander, GNJ Tytgat (eds). New York, Plenum Medical, 1993, pp. 127-140.
25. Szabo S, Vattay P, Scarbrough E, Folkman J. Role of vascular factors, including angiogenesis, in the mechanism of action of sucralfate. Am J Med 1991; 91: 158S.
26. Wang JY, Nagai H, Okabe S. Effect of omeprazole on the delayed healing of acetic acid-induced gastric ulcers in rats. Jpn J Pharmacol 1990; 54: 82-85.